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Introduction
Drug detection dogs are used throughout the military and law enforcement to assist in locating and identifying controlled substances during searches and inspections. Recognizing the growing requirements of a military working dog (MWD) program, the Department of Defense established a training facility at Lackland Air Force Base in Texas. The program utilizes special training aids consisting of ventilated canisters containing one of the common street drugs. The Naval Criminal Investigative Service Regional Forensic Laboratory (NCISRFL) in Norfolk, VA has been the sole provider of these training aids to the Department of Defense, and because of the relatively high volume of production, the potential for passive exposure to cocaine and other controlled substances has been a concern. In response to the potential risk of exposure, urine analysis testing has been performed on the laboratory employees since 1995. These tests have been performed by the Navy Drug Screening Laboratory in Jacksonville, FL since implementation of the monitoring program.
Several researchers have investigated passive cocaine exposure in medical and occupational settings and have demonstrated the risks of handling cocaine (1--4). The potential for dermal absorption of cocaine on unprotected skin during the application of cocaine as a local anesthetic or vasoconstrictor in medical procedures was previously reported (1). In the study, the cutaneous application of a 5-rag dose of cocaine in solution resulted in maximum urinary levels of 55 ng/mL of benzoylecgonine (BZE). In another study, E1Sohly (2) examined the potential for passive exposure with a single subject handling contaminated dollar bills and concluded that the handling of cocaine contaminated articles would not result in a positive BZE test at the Department of Health and Human Services immunoassay screening cutoff level of 300 ng/mL, but that absorption did occur leading to low urinary levels of BZE from the handling of currency. A maximum concentration of 72 ng/mL was observed for a single subject during the investigation.
In law enforcement settings, individuals in the immediate vicinity of seized evidence could inhale airborne cocaine dust or handling handle material contaminated with cocaine dust resulting in passive absorption. Le et al. (3) demonstrated the handling of cocaine could result in high urine BZE levels, including one case in which a 1570 ng/mL urine concentration was observed for an employee who sampled 50 kg of cocaine hydrochloride over a 3-h period. As documented in a previous report on cocaine exposure by NCISRFL employees, 28 of 233 human urine samples collected from individuals participating in the preparation of training aids contained BZE detectable by gas chromatography-mass spectrometry (GC-MS) (4) .
In addition to health concerns, the inhalation of cocaine aerosols or cocaine dust is of special concern to medical personnel, laboratory technicians, and law enforcement agencies because many of these personnel are subject to mandatory random drug testing. The primary goal of the current study was to elucidate the routes of exposure during preparation of the training aids and implement procedural changes to minimize the occupational exposure. In the present study, the cocaine exposure was evaluated for NCISRFL employees preparing the training aids, other administrative employees, and laboratory personnel sharing the same work spaces. NCISRFL employees exposed to cocaine during the preparation of training aids were evaluated with respect to cocaine levels in their personal breathing zone (PBZ), use of gloves and respirators, and the presence of urine BZE as a marker for cocaine exposure. The experiments were performed first utilizing current practice to establish a baseline and to identify potential sources of exposure. Following several procedural changes to the manufacturing process, a follow-up study was performed to determine the effectiveness of the changes.
Materials and Methods

Study design
A series of control groups and monitoring stations were designed to identify routes of administration exposure and measure aerosolized cocaine concentrations at each step in the process. This was accomplished by monitoring ambient cocaine levels in three separate zones located in the laboratory facility. Specifically, air samples were taken in the main laboratory where training aid preparation was performed, in an adjacent laboratory (Latent Prints Laboratory) that has open access to the main laboratory, and in an administrative office physically separated from the main laboratory. Additionally, employees working in the main laboratory wore mechanical impingers to collect air samples at a controlled rate within their PBZ during each step in the manufacturing process.
Employees in each group were also monitored for exposure by collecting urine samples and testing for BZE. During training aid preparation, urine samples were collected throughout the day for subjects in groups I-V for the baseline study and groups |-III for the follow-up study. In general, samples were collected from each technician at the beginning of the shift, mid-shift, and at the end of the shift. Control groups for the baseline study were delineated by laboratory function and potential for exposure (Table I) . For the baseline study, group I consisted of one employee from the main laboratory involved in the process of grinding of cocaine from the seized material. Group II consisted of three employees from the main laboratory involved directly in the preparation of the training aids. Employees working in the main laboratory but not involved in training aid preparation were designated as group III. Group IV consisted of two employees working in the Latent Prints Office and group V employees included four administrative employees not directly exposed and one laboratory visitor exposed for less than 4 h.
In the initial study, only the grinding function was performed in a laboratory hood; other process steps were conducted on a laboratory bench in the main laboratory. Subjects A, B, C, and D wore respirators but had not been fit tested at the time (5). In the follow-up study several significant changes were made to the procedure (6). All manufacturing functions were performed in a laboratory hood during the follow-up study, and subjects A, B, C, and D were fit-tested for NIOSH approved filtering face piece particulate respirators (3M 9211 or 9210). Subjects A, B, C, and D were also provided with more rigorous training in the use of PPE prior to the follow-up study. In both the baseline and follow-up studies, subjects A, B, C, and D wore comparable gloves and laboratory coats throughout the manufacturing process. 
Manufacture of training aids
The manufacture of the training aid consisted of four process steps, including grinding, weighing, stuffing, and sealing. Seized cocaine samples in excess of the amount required for preparation were ground to a fine powder using a mortar and pestle. Once ground, the cocaine was weighed using an analytical balance in 1-, 2-, 3-, and 5-g amounts. The weighed samples were transferred or "stuffed" into pre-folded filter paper (Whatman #4) bindles and stapled. The bindles were placed into 3-oz. tin, seamless, slipcover-ventilated, canisters (United States Can Company, Baltimore, MD). The canister consists of two pieces with seven pre-punched holes in each part for ventilation of the cocaine odor. The containers were washed with unscented soap prior to use to remove any oil from the manufacturing process. After placement of the cocaine, the canister was sealed with wire and secured with a forensic lead disc seal.
Impinger and urine samples
Personal breathing zones were monitored for groups I and II using a personal air sampling pumps in conjunction with a glass impinger. These employees were most likely to have significant exposure and were considered more critical to the investigation. The personal air sampler (SKC Inc., Eight Four, PA) provided a constant flow of approximately 1 L/rain ambient air. Particulates in the air stream, including aerosolized cocaine, were entrapped and dissolved in the aqueous solution of the impinger. The impinger consisted of a glass flask, stopper, and tapered glass tube. Air drawn by the air pump through the glass tube is bubbled through 15 mL of aqueous solution containing ascorbic acid (20 mg/mL). Solutions from the impinger apparatus were transferred to plastic vials for subsequent analysis by GC-MS. Samples were also collected the day before aid preparation to demonstrate a negative baseline.
Extraction of BZE and cocaine
Benzoylecgonine was extracted using a Speedisk 48 TM positive-pressure extraction manifold (San Pedro, CA) as previously described (7). The limit of detection (LOD) was determined to be 12 ng/mL using a 2-mL urine aliquot. Cocaine was extracted by the same method described, except that in the initial step, 0.1 mL of internal standard (cocaine-d3, 0.0025 mg/mL) and 1.0 mL of 1.0M phosphate buffer (pH 6.0) were added to 5-mL aliquots of the acidified impinger solutions in a 50-mL tube.
The BZE samples were derivatized by the addition of 0.025 mL pentafluoropropanol (PFPOH) and 0.05 mL of pentafluoropropionic anhydride (PFPA) added directly into the ALS vials. PFPA and PFPOH were purchased from United Chemical Technologies (Bristol, PA). Derivatization was not required for the analysis of cocaine.
GC-MS procedure for cocaine and BZE
An Agilent 6890 GC coupled to a 5972 or 5973 MSD (Agilent, Paio Alto, CA) operated in electron-impact selected ion monitoring (EI-SIM) mode was used for the analysis as described by yon Minden and D'Amato (8) . For cocaine analysis, three ions (m/z 303, 272, and 182) were monitored and two ions (m/z 306 and 275) for the internal standard, cocaine-d3. The quantitation ratio (cocaine/cocaine-da) was m/z 303/306, and the qualifiers for identification were the m/z 272/303 and 182/303 ratios. The qualifier ion ratio for the internal standard, cocained3, was m/z 275/306. Cocaine concentrations for samples and controls were determined by single-point calibration against the 50-ng/mL cocaine calibrator using the m/z 303/306 cocaine/cocaine-d3 ion ratio. An LOD of 5 ng/mL was observed for the cocaine assay.
Three ions (m/z 210, 272, 331) were monitored for BZE and two ions (m/z 334 and 213) for the internal standard, BZE-d3. The quantitation ratio (BZE/BZE-d3) was m/z 210/213, and the qualifiers for identification were the m/z 272/210 and 331/210 ratios. The qualifier ion ratio for the internal standard, BZE-d3, was m/z 334/213. BZE concentrations for samples and controls were determined by single-point calibration against the 100-ng/mL BZE calibrator using the m/z 210/213 BZE/BZE-d 3 ion ratio. The LOD for BZE was calculated at 12 n~mL.
Calculations
Eight-hour time-weighted averages were calculated from multiple air samplings made during each process step to obtain an average exposure for an entire shift. Cocaine concentrations (ng/mL) obtained from the air sampling devices were converted to air concentration (mg/m a) using measured flow rates (L/min) and assuming a 100% recovery of cocaine in the acidic solution. The general formula
where TWA is the average exposure in mg/m a, C (mg/m 3) is concentration measured in sampling N, and TN is the duration of sampling N in hours (h) was utilized. Subjects in groups [ and II were monitored for each of the four manufacturing steps of varying time duration (9) . LODs for airborne cocaine (Table II) are derived from the instrumental LOD of cocaine (5 ng/mL), flow rate in L/rain, and time of collection in minutes. As a consequence, the limits may vary depending on collection time.
Results and Discussion
The described experiments evaluated three testing parameters in determining the effectiveness of the procedural changes in reducing cocaine exposure. These parameters included urine BZE concentrations, airborne cocaine (three collection points), and the levels of cocaine in the personal breathing zones of groups I and II. The baseline study required the production of Table I provides a complete listing of subjects, group designation, and urine testing results. Positive specimens were observed in groups I, II, III, and IV. The highest concentration (47 ng/mL) was observed for subject A the morning following the grinding process. In the follow-up study (Table  I) , samples were collected from six subjects from groups I, It, III, and IV. Three samples collected the morning after production on February 15 had detectable BZE. Samples with concentrations above the LOD and acceptable chromatography were reported quantitatively. Other samples that exhibited the characteristic ions for BZE, but below the LOD, were reported as less than the LOD.
Urine concentrations of BZE provided the best marker for cocaine exposure. During the baseline study, samples were colleted from subjects in each of the categories (I-V). BZE was detected in groups I, II, III, and IV. All samples collected prior to the start of aid manufacture contained no detectable BZE. Subjects in groups I and II provided five or six samples with several collected at different points during training aid production. The highest BZE concentrations were observed in groups I and II, and none was detected in group V. Subjects submitted between one and six samples and in general, samples were collected before during, and after training aid production. Table III describes in detail the urine BZE concentrations for subjects A, B, C, and D. There appears to be a decrease in BZE concentrations for subjects A, C, and D, and an apparent increase for subject B. However, long-term tracking of urine BZE will be needed to establish trends.
The airborne concentrations were generally lower than those observed during PBZ monitoring but may have contributed to the overall exposure (Table II) . Two relatively high concentrations of 0.0210 and 0.010 mg/m 3 were detected in the followup study, and an airborne concentration of 0.0144 mg/m 3 was also observed in the baseline study. In addition, Group V subjects tested negative for BZE during the baseline study, but airborne cocaine levels were less than the limits of detection for each sampling. Essentially, the direct effect of airborne cocaine on exposure could not be determined from available data.
The results described in Table IV represent the 8-h TWAs for subjects A, B, C, and D. Subject A performed the grinding for both studies and was monitored for less than a hour during both studies. Subjects B, C, and D performed essentially the same function, performing each manufacturing task in rotation. Subject D exhibited the highest cocaine level (0.06944 mg/m 3) and the largest decrease at 83%. However, there were no observed differences in job function that would account for the difference. Nonetheless, significant decreases in concentration were observed for all subjects indicating that improvements in engineering controls, such as a greater use of the laboratory hood, reduced the level of aerosolized cocaine. Table V provides greater detail of the relationship between PBZ concentration and function. The grinding of cocaine during the baseline study produced the highest concentration overall but was performed for only 35 min. The highest urine BZE concentration was also observed for subject A during the baseline study. The results are more variable for the manufacturing process with no apparent trends that would indicate one specific function produced more aerosolized cocaine than another. However, in nearly every instance the concentrations were lower during the follow-up study for each function.
Subjects A, B, C, and D were also administered the Addiction Research Center Inventory (ARCI) and a single-dose questionnaire subsequent to preparing the training aids. The Drug Effects Questionnaire (DEQ) was also given to the subjects. The ARCI includes 49 questions relating to impairment. The DEQ uses a list of 26 adjectives including sleepiness, dizziness, and restless. The subject rates each adjective from "not at all" to "extremely." In the single dose questionnaire, the subject responds to the following basic questions: (1) Do you feel the medicine? (2) What type of medicine is it? (3) They respond "yes" or "no" to a series of descriptive phrases related to drug sensation such as relaxed, skin itchy, high, and nervous. (4) Do you like the medicine? The subjects provided negative responses to all question indicating no perceived effects from the exposures. These results support conclusions by Fitzmaurice et al. (1) , that is, low levels of urine BZE can be observed without the subject exhibiting the signs of clinical toxicity.
Conclusions
These results were consistent with previous reports (1-4, 10,11) and indicated that the handling of cocaine can result in passive exposure as established by the presence of BZE in the urine of observed subjects. The described studies also demonstrated some effectiveness in reducing occupational exposure to cocaine for the employees of NCISRFL, Norfolk, VA. The modest improvements in urine BZE concentration suggest that the proper use of PPE including gloves, respirators, and laboratory coats can mitigate occupational exposure to cocaine. The increased use of ventilation hoods also appears to have reduced the risk of exposure by reducing PBZ cocaine levels during training aid preparation. 
